Yasutoshi Fujii

Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib

Yasutoshi Fujii, Atsushi Ono, C. Nelson Hayes et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 49 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma

Masami Yamauchi, Atsushi Ono, Kei Amioka et al. · Communications Medicine · 2023 · 35 citations · Full text

Medicine, Immunology, Oncology +17

The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma

Peiyi Zhang, Atsushi Ono, Yasutoshi Fujii et al. · International Journal of Cancer · 2022 · 34 citations

Medicine, Immunology, Oncology +17

Real-world efficacy and safety of durvalumab–tremelimumab as second-line systemic therapy after atezolizumab–bevacizumab in unresectable hepatocellular carcinoma

Ryoichi Miura, Atsushi Ono, Shigeki Yano et al. · Medicine · 2024 · 16 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma

Shigeki Yano, Tomokazu Kawaoka, Shintaro Yamasaki et al. · Cancers · 2023 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +13